Diabetes-Metabolism Research and Reviews

Papers
(The H4-Index of Diabetes-Metabolism Research and Reviews is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
364
Issue Information258
Plasma ANGPTL7 Links Insulin Resistance to Heart Failure: Unveiling a Novel Fibro‐Metabolic Axis in Type 2 Diabetes158
The circadian syndrome is a predictor for cognition impairment in middle‐aged adults: Comparison with the metabolic syndrome157
Central and Peripheral Sensitivity to Thyroid Hormones Correlate to Metabolically Obesity Phenotypes in Chinese Euthyroid Adults: A Cross‐Sectional Study149
Early Postpartum Metabolic Heterogeneity Among Women Who Progressed to Type 2 Diabetes After Gestational Diabetes: A Prospective Cohort103
Longitudinal cardiovascular health measured by life's essential 8 metrics with incident diabetes: A 13‐year prospective cohort study99
Effects of treatment with Glucagon‐like peptide‐1 receptor agonist on prediabetes with overweight/obesity: A systematic review and meta‐analysis98
Vision Loss as a Rising Global Health Challenge: Comprehensive Analysis of High Fasting Plasma Glucose Burden and Projections to 203587
Efficacy and safety of fixed‐ratio combination insulin degludec/liraglutide in type 2 diabetes: A systematic review and meta‐analysis of randomised controlled trials79
Issue Information70
Charcot neuroarthropathy in persons with diabetes: It's time for a paradigm shift in our thinking66
Guidelines on the diagnosis and treatment of active Charcot neuro‐osteoarthropathy in persons with diabetes mellitus (IWGDF 2023)62
The role of long non‐coding RNAs in the development of diabetic kidney disease and the involved clinical application60
59
Stuttering in adolescence and the risk for dysglycemia in early adulthood58
The relationship between neonatal hypoglycaemia and cord blood C‐peptide levels in neonates of birthing individuals with type 1 diabetes53
Endostatin, soluble tumour necrosis factor receptor 1 and soluble tumour necrosis factor receptor 2 cannot predict new onset of microalbuminuria in patients with type 2 diabetes52
Predictors of change in hypoglycemia unawareness among patients with type 1 diabetes52
Assessment of the spectrum of depression and bipolarity in patients with type 1 diabetes49
Withdrawal: Screening for people with glucose metabolism disorders within the framework of the DEMOJUAN project (DEMOnstration area for primary prevention of type 2 diabetes, JUAN Mina and Barranquill48
Determinants of Prediabetes in Adolescents: Evidence From Indonesia47
Microbiome‐modulating nutraceuticals ameliorate dyslipidemia in type 2 diabetes: A systematic review, meta‐analysis, and meta‐regression of clinical trials44
Development of a Chinese‐Specific Clinical Model to Predict Maturity‐Onset Diabetes of the Young42
Classification of foot ulcers in people with diabetes: A systematic review40
Issue Information40
Prevalence and risk factors of diabetic peripheral neuropathy: A population‐based cross‐sectional study in China39
37
N‐Lactoyl Amino Acids: Emerging Biomarkers in Metabolism and Disease36
Sex differences in the relationship between platelet count and type 2 diabetes risk in community‐dwelling adults: Longitudinal findings over 14 years36
Cover Image36
Cost‐Effectiveness of Artificial Intelligence Assisted Screening for Diabetic Retinopathy: A Markov Model36
A multidisciplinary team reduces in‐hospital clinical complications and mortality in patients with diabetic foot ulcers35
Risk of New‐Onset Ischaemic and Haemorrhagic Stroke in Patients With Type 2 Diabetes With Chronic Kidney Disease on SGLT‐2 Inhibitor Users: A Population‐Based Cohort Study35
Comment on ‘Glycaemic Status Modifies the Association Between Cardiometabolic Index and Cardio‐Kidney Outcomes: A Multi‐Cohort Analysis’34
Machine Learning‐Assisted Analysis of Sublingual Microcirculatory Dysfunction for Early Cardiovascular Risk Evaluation and Cardiovascular‐Kidney‐Metabolic Syndrome Stage in Patients With Type 2 Diabet34
2.8120369911194